美股异动 | 出售最高2000万美元普通股 GlucoTrack(GCTK.US)飙升超123%

Core Insights - GlucoTrack (GCTK.US) experienced a significant increase of over 123%, reaching a price of $10.91 [1] - The company announced an agreement with Sixth District Capital to sell up to $20 million in common stock [1] - GlucoTrack specializes in developing implantable continuous glucose monitoring devices that directly measure blood glucose levels, eliminating lag time, and are suitable for diabetes patients [1]